| Heart disease and stroke statistics—2014 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ... circulation 129 (3), e28-e292, 2014 | 68570* | 2014 |
| 2013 ESH/ESC Guidelines for the management of arterial hypertension G Mancia, R Fagard, K Narkiewicz, J Redon, A Zanchetti, M Böhm, ... Arterial Hypertension 17 (2), 69-168, 2013 | 33675* | 2013 |
| The effect of spironolactone on morbidity and mortality in patients with severe heart failure B Pitt, F Zannad, WJ Remme, R Cody, A Castaigne, A Perez, J Palensky, ... New England Journal of Medicine 341 (10), 709-717, 1999 | 12067 | 1999 |
| ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 … Authors/Task Force Members, JJV McMurray, S Adamopoulos, SD Anker, ... European heart journal 33 (14), 1787-1847, 2012 | 11791 | 2012 |
| Heart disease and stroke statistics 2005 update American Heart Association http://www. americanheart. org/statistics/, 2005 | 8600* | 2005 |
| European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) The Fifth Joint Task Force of the European Society of Cardiology and Other … European Journal of Preventive Cardiology 19 (4), 585-667, 2012 | 7276 | 2012 |
| ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 … Authors/Task Force Members, K Dickstein, A Cohen-Solal, G Filippatos, ... European heart journal 29 (19), 2388-2442, 2008 | 6992 | 2008 |
| Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction B Pitt, W Remme, F Zannad, J Neaton, F Martinez, B Roniker, R Bittman, ... New England Journal of Medicine 348 (14), 1309-1321, 2003 | 6331 | 2003 |
| Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global … H Wang, M Naghavi, C Allen, RM Barber, ZA Bhutta, A Carter, DC Casey, ... The lancet 388 (10053), 1459-1544, 2016 | 5614 | 2016 |
| 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with … Authors/Task Force Members, SG Priori, C Blomström-Lundqvist, ... Ep Europace 17 (11), 1601-1687, 2015 | 5459 | 2015 |
| 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and … F Cosentino, PJ Grant, V Aboyans, CJ Bailey, A Ceriello, V Delgado, ... European heart journal 41 (2), 255-323, 2020 | 4725 | 2020 |
| Cardiovascular and renal outcomes with empagliflozin in heart failure M Packer, SD Anker, J Butler, G Filippatos, SJ Pocock, P Carson, ... New England Journal of Medicine 383 (15), 1413-1424, 2020 | 4500 | 2020 |
| Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials CT Trialists The Lancet 376 (9753), 1670-1681, 2010 | 4431* | 2010 |
| Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer SJ Antonia, A Villegas, D Daniel, D Vicente, S Murakami, R Hui, T Yokoi, ... New England Journal of Medicine 377 (20), 1919-1929, 2017 | 4334 | 2017 |
| Eplerenone in patients with systolic heart failure and mild symptoms F Zannad, JJV McMurray, H Krum, DJ van Veldhuisen, K Swedberg, H Shi, ... New England Journal of Medicine 364 (1), 11-21, 2011 | 3816 | 2011 |
| Empagliflozin in heart failure with a preserved ejection fraction SD Anker, J Butler, G Filippatos, JP Ferreira, E Bocchi, M Böhm, ... New England Journal of Medicine 385 (16), 1451-1461, 2021 | 3573 | 2021 |
| Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both MA Pfeffer, JJV McMurray, EJ Velazquez, JL Rouleau, L Køber, ... New England Journal of Medicine 349 (20), 1893-1906, 2003 | 3390 | 2003 |
| Alogliptin after acute coronary syndrome in patients with type 2 diabetes WB White, CP Cannon, SR Heller, SE Nissen, RM Bergenstal, GL Bakris, ... New England journal of medicine 369 (14), 1327-1335, 2013 | 3174 | 2013 |
| Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial CM O’Connor, DJ Whellan, KL Lee, SJ Keteyian, LS Cooper, SJ Ellis, ... Jama 301 (14), 1439-1450, 2009 | 2591 | 2009 |
| Rosuvastatin and cardiovascular events in patients undergoing hemodialysis BC Fellström, AG Jardine, RE Schmieder, H Holdaas, K Bannister, ... New England Journal of Medicine 360 (14), 1395-1407, 2009 | 2359 | 2009 |